TREATMENT PHARMA ApS: Financial statements 2020
CVR: 37208035
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TREATMENT PHARMA ApS (CVR 37208035) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,351 and a net result of DKK 162,827 compared with DKK -5,045 the year before. Equity in the 2020 report amounted to DKK -2,538.
- Gross Profit
- DKK -3,351
- Profit/Loss
- DKK 162,827
- Equity
- DKK -2,538
- Total Assets
- DKK 1,999
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -3 t. | 163 t. | -3 t. | - |
| 2019 | - | -3 t. | -5 t. | -165 t. | 1 |
| 2018 | - | -7 t. | -53 t. | -160 t. | - |
| 2017 | - | -10 t. | -12 t. | -107 t. | - |
Official annual report
How creditworthy is TREATMENT PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TREATMENT PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -3,443, and the net result was DKK -5,045.
About TREATMENT PHARMA ApS
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.